©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 106198
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.106198
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.106198
Table 2 Clinicopathological characteristics before and after propensity score-matching adjusting for major clinical parameters including sex, age, pathological T stage, pathological N stage, reconstructive techniques and laparoscopic approach
| Variables | Before PSM | After PSM | ||||||
| NAFLD (n = 52) | Controls (n = 1070) | P value | SMD | NAFLD (n = 52) | Controls (n = 208) | P value | SMD | |
| Surgery time (minutes), mean (SD) | 198.9 (52.7) | 189.2 (46.5) | 0.144 | 0.195 | 198.9 (52.7) | 194.6 (47.1) | 0.704 | 0.087 |
| Complication | 0.927 | 0.046 | 0.608 | 0.121 | ||||
| Yes (%) | 5 (9.6) | 118 (11.0) | 5 (9.6) | 28 (13.5) | ||||
| No (%) | 47 (90.3) | 952 (89.0) | 47 (90.3) | 180 (86.5) | ||||
| Complication (Grade III to V) | 1 | 0.053 | 1 | 0.053 | ||||
| Yes (%) | 2 (3.8) | 31 (2.9) | 2 (3.8) | 6 (2.9) | ||||
| No (%) | 50 (96.2) | 1039 (97.1) | 50 (96.2) | 202 (97.1) | ||||
| T stage | 0.438 | 0.383 | 0.886 | 0.171 | ||||
| T1 (%) | 32 (61.5) | 540 (50.5) | 32 (61.5) | 126 (60.6) | ||||
| T2-3 (%) | 11 (21.1) | 370 (34.6) | 11 (21.1) | 48 (23.1) | ||||
| T4 (%) | 9 (17.3) | 160 (15.0) | 9 (17.3) | 34 (16.3) | ||||
| N stage | 0.028a | 0.531 | 0.809 | 0.176 | ||||
| N0 (%) | 38 (73.1) | 587 (54.9) | 38 (73.1) | 152 (73.1) | ||||
| N1-2 (%) | 7 (13.5) | 288 (26.9) | 7 (13.5) | 30 (14.4) | ||||
| N3 (%) | 7 (13.4) | 195 (18.2) | 7 (13.4) | 26 (12.5) | ||||
| pTNM stage (AJCC 8th) | 0.123 | 0.502 | 0.846 | 0.251 | ||||
| I A-B (%) | 34 (65.4) | 564 (52.7) | 34 (65.4) | 142 (68.3) | ||||
| II A-B (%) | 8 (15.4) | 219 (20.5) | 8 (15.4) | 32 (15.4) | ||||
| III A-C (%) | 10 (19.2) | 287 (26.8) | 10 (19.2) | 34 (16.3) | ||||
| Neural invasion | 0.067 | 0.306 | 0.521 | 0.133 | ||||
| Yes (%) | 9 (17.3) | 323 (30.2) | 9 (17.3) | 47 (22.6) | ||||
| No (%) | 43 (82.7) | 747 (69.8) | 43 (82.7) | 161 (77.4) | ||||
| Vascular invasion | 0.687 | 0.080 | 0.479 | 0.135 | ||||
| Yes (%) | 14 (26.9) | 327 (30.6) | 14 (26.9) | 44 (21.2) | ||||
| No (%) | 38 (73.1) | 743 (69.4) | 38 (73.1) | 164 (78.8) | ||||
| Retrieved lymph nodes [mean (SD)] | 39.2 (12.3) | 42.5 (11.1) | 0.040a | 0.279 | 39.2 (12.3) | 42.5 (12.5) | 0.058 | 0.271 |
| Positive lymph nodes [mean (SD)] | 3.4 (8.8) | 3.27 (6.1) | 0.868 | 0.020 | 3.4 (8.8) | 3.0 (7.0) | 0.949 | 0.058 |
| Positive lymph nodes rate [mean (SD)] | 0.56 (1.04) | 0.79 (1.02) | 0.112 | 0.224 | 0.56 (1.04) | 0.55 (1.02) | 0.992 | 0.005 |
- Citation: Zou YF, Zhang YG, Zhao ZC, Li Z, Liu HD, Li QY, Chen ZT, Zhu CJ, Liu HT, Wang JW, Li FY, Wang LJ, Zhang DC, Yang L, Xu H, Xu ZK, Wang S. Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy. World J Gastrointest Surg 2025; 17(9): 106198
- URL: https://www.wjgnet.com/1948-9366/full/v17/i9/106198.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.106198